trial · primary record
empasiprubart
Chronic Inflammatory Demyelinating Polyneuropathy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 218 |
| Primary completion | 2030-09 |
| Primary endpoint | Reduction of ≥1 point compared with baseline in aINCAT score at week 24 |
| Registry ID | NCT06920004 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:38.816Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06920004
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.